Rob Yang Ph.D, Mba Email and Phone Number
Rob Yang Ph.D, Mba work email
- Valid
- Valid
Rob Yang Ph.D, Mba personal email
- Valid
Leveraging human biology, translational sciences & data analytics to deliver preventative and therapeutic impact to patients.Rob is the Head of Advanced Predictive Analytics at J&J where his team focuses on using AI/ML for early disease detection, risk stratification & early interception. By combining human ‘omics & digitized biomarkers, Rob and team decode risk trajectories & mechanisms to enable therapeutic solutions for lung cancer, renal cancer & autoimmune diseases. Before joining J&J, Rob headed the predictive analytics function within the inflammation and immunology research unit at Celgene. He also served as Director of Computational Biology of neuroscience at AstraZeneca and held roles of increasing responsibility at Pfizer covering CNS diseases. Rob is working towards an executive MBA at the MIT Sloan School of Management. He did his postdoc research in systems biology at Harvard Medical School, received computational biology Ph.D from the Washington University in St. Louis School of Medicine, and a Bachelor of Science in computer science and bioinformatics from the University of Alberta.
Cartabio
View- Website:
- cartabio.ai
- Employees:
- 3
-
Co-Founder, CeoCartabio Mar 2023 - PresentWhat if we could "see" cells in diseases, "understand" their language, and “normalize” the pathogenic cell-cell crosstalk? CartaBio decodes cellular intelligence with proprietary scalable spatial single-cell tech & self-learning AI to dissect the right causal disease biology that enhances therapeutic success.
-
Global Head, Advanced Predictive Analytics, Wwda/LciJohnson & Johnson Oct 2019 - Mar 2023New Brunswick, Nj, UsBuilt & lead the global data science organization to:- Apply advanced AI/ML to predict, diagnose & intercept diseases early on;- Patient stratification & target ID via genetics, molecular omics, digital biomarkers, imaging and RWE;- Partner & collaborate externally in consortia, partnerships and academic research;- Strengthen innovative capabilities in single-cell genomics, multi-modal modeling and digital health;- Discover & validate non-invasive and tissue-based biomarkers for future risk, diagnoses & prognoses;Disease focus:- Lung cancer, Renal cancer, Type 1 Diabetes, Atopic Dermatitis, Pediatric allergy diseases;Actively fostered a strong data science community -Sponsored the MarkCuban Foundation AI Bootcamp; -Co-organized the MIT Healthcare Conference 2021, 2022; -Founded the MIT data science forum; -
Head, Predictive Analytics, I&I TcoeCelgene Jun 2016 - Oct 2019Summit, New Jersey, UsBuilt & lead the predictive analytics team within the inflammation and immunology research unit.-Target entry, functional genomics MoA, translational biomarkers to segment patient subpopulation and human biology profiling to back-translate to feed the pre-clinical pipelines;-Authored & executed 3-year computational platform roadmap for autoimmune diseases;Co-chair of the new target forum;Member of the global predictive analytics leadership team;Member of the I&I research unit leadership team; -
Director, Computational Biology, Imed NeuroscienceAstrazeneca Jan 2016 - Jun 2016Cambridge, Cambridgeshire, GbFunctional head-Led the computational biology effort within the neuroscience group to support internal pipeline of target entry to translational medicine;-Championed external partnership and consortia efforts;-Initiated target profiler concept to facilitate neuro-specific target evaluation;-Evaluated CRO, software, vendors;Member of the global data science committee.Our boston site was a flexible and innovative setup, but unfortunately was a victim of site closure. Truly wished we had more time. -
Principal ScientistPfizer 2014 - Jan 2016New York, New York, UsLead computational biology effort in determining MoA for projects.Lead human biology effort.Continued consortia efforts. -
Senior ScientistPfizer Mar 2013 - May 2014New York, New York, UsAnalyzed, mined and integrated in-house and public omics datasets to inform/guiding neuroscience projects.Lead exploratory modeling efforts in longitudinal natural history human cohorts and early-phase clinical data.Interfaced with external collaboration.
-
Postdoc Research FellowHarvard Medical School Sep 2009 - Mar 2013Boston, Ma, UsThe research project was a joined collaboration between Harvard medical school, MIT and Boehringer Ingelheim that focused on therapeutic target-identification for the treatment of rheumatoid arthritis (RA). We used systems biology approach to experimentally probe, and computationally modeled the differences between the cellular states of normal and RA cells, under combinations of stimuli/perturbations. -
Ph.DWashington University School Of Medicine 2004 - 2009St. Louis, Mo, UsMy grad school research (advisor: Garland Marshall) focused on computer-aided drug design. The project utilized virtual screening and pharmacophore-based drug design to predict small-molecule candidates that targeted the dimerization of ErbB receptors. I then experimentally tested these early candidates by using an array of assays that included Western and split-luciferase live-cell imaging. -
Undergrad Research AssistantUniversity Of Alberta 2002 - 2004Edmonton, Ab, CaI worked in the lab of professor David Wishart at the University of Alberta. I worked on a few projects during my 2 year tenure in Dave's lab. The first project was RDC-aided protein structure prediction. This was a nice introduction to the field of protein folding, which I later on was able to appreciate just how complex/hard it is. The second project was on building a computational cellular automata that provided a simulator for the users to build predictive models by supplying physical rules.
Rob Yang Ph.D, Mba Skills
Rob Yang Ph.D, Mba Education Details
-
Mit Sloan School Of ManagementMaster Of Business Administration - Mba -
Washington University School Of Medicine In St. LouisHighthrouput Screening
-
University Of AlbertaBioinformatics
Frequently Asked Questions about Rob Yang Ph.D, Mba
What company does Rob Yang Ph.D, Mba work for?
Rob Yang Ph.D, Mba works for Cartabio
What is Rob Yang Ph.D, Mba's role at the current company?
Rob Yang Ph.D, Mba's current role is Founder CEO CartaBio | Model-Guided AI Drug Discovery | WUSTL, Harvard, MIT.
What is Rob Yang Ph.D, Mba's email address?
Rob Yang Ph.D, Mba's email address is ry****@****jnj.com
What schools did Rob Yang Ph.D, Mba attend?
Rob Yang Ph.D, Mba attended Mit Sloan School Of Management, Washington University School Of Medicine In St. Louis, University Of Alberta.
What skills is Rob Yang Ph.D, Mba known for?
Rob Yang Ph.D, Mba has skills like Bioinformatics, Computational Biology, Molecular Biology, Matlab, Systems Biology, R, Cell Culture, Cell Biology, Western Blotting, Python, Microscopy, Cell.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial